Carlsbad, CA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Company on track to report topline data in first half of 2025Positive preliminary data from all five single ascending dose (SAD) cohorts ranging ...

This approval follows the drug's previous sanction for ulcerative colitis in October 2023. According to InvestingPro analysis, Eli Lilly maintains an exceptional gross profit margin of 81%, ...

Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD), but it can cause body-wide effects that may impair a person’s oral health. Mouth sores, gum disease, and dry mouth are ...

Biomerica received notices of allowance for patents addressing Gastroesophageal Reflux Disease (GERD), Crohn’s Disease, and Ulcerative Colitis. These patents cover markets under the European ...

Unfortunately, ulcerative colitis can occur in anyone, including pregnant women. But that does not mean you do not plan for a family. With proper management and treatment, women can experience a ...

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...

Pharmaceutical manufacturers make long-acting, intermediate-acting, and short-acting insulin options. If you do inject insulin, the best way to start a treatment ... For this chart, we’ll ...

Research has indicated that many people who have mild-to-moderate ulcerative colitis benefit from making changes to their diet in conjunction with other treatments (such as medication). As with any ...

3,4 The clinician is now faced with two decisions when considering using an IL-23 for their patients with ulcerative colitis. First, where should IL-23s inhibitors as a class be considered in the ...